chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Certain parts of body will get really itchy and red and then goes away; Certain parts of body will get really itchy and red and then goes away; all over hives/rash; all over hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (all over hives), ERYTHEMA (Certain parts of body will get really itchy and red and then goes away), PRURITUS (Certain parts of body will get really itchy and red and then goes away) and RASH (all over hives/rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jul-2021, the patient experienced URTICARIA (all over hives) and RASH (all over hives/rash). On an unknown date, the patient experienced ERYTHEMA (Certain parts of body will get really itchy and red and then goes away) and PRURITUS (Certain parts of body will get really itchy and red and then goes away). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL N) for Hives, at a dose of 1 dosage form and METHYLPREDNISOLONE for Hives, at a dose of 1 dosage form. At the time of the report, URTICARIA (all over hives) and RASH (all over hives/rash) had resolved and ERYTHEMA (Certain parts of body will get really itchy and red and then goes away) and PRURITUS (Certain parts of body will get really itchy and red and then goes away) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient did not use any concomitant medications
Hint aches throughout body; very fatigued; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 15Feb2021 12:30 (at 76 years old) (Batch/Lot Number: EN6201) as 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 16Feb2021, patient experienced Hint aches throughout body and very fatigued. No treatment for the events. The outcome of the events was not recovered. No other vaccine_in_four weeks. No covid_prior_vaccination. Not covid tested post vaccination.
Information has been received from a pharmacist concerning a 76 year old male patient with penicillin allergy who on 07-SEP-2010 was vaccinated intramuscularly with a 0.5mL dose of PNEUMOVAX 23 (lot # 665708/0651Z). The pharmacist stated that on 08-SEP-2010 the patient developed a palm size erythema on the inner aspect of the upper arm. It is unknown whether this was the patient's first dose of PNEUMOVAX 23. The patient was treated with BENADRYL 50mg, twice a day for two days. At the time of report, the patient was recovering from palm size erythema on the inner aspect of the upper arm. The patient sought medical attention. Developed a palm size erythema on the inner aspect of the upper arm was considered to be an other important medical event due to treatment with BENADRYL by the pharmacist. This is one of two reports received from the same source. The pharmacist requested a lot check. A lot check has been initiated. No further information is available.
Event is that patient was given expired vaccine. No adverse reactions to vaccine have been noted or reported.  Vaccine expired on 9/30/22, was not pulled from fridge and was give today.  Box is listed by manufacturer with manufacturing date only and expires 12 months from manufacturing date (10/21).  Manufacturer not able to provide data to support stability of the vaccine, CDC recommendations are to revaccinate.  I have left a message to advise parents and patient of this - as of this time I have not heard back from them, but when I do, I will advise them of the recommendation to come in and repeat booster.
Almost immediately after injection, right arm became immediately swollen and developed a red botchy rash. After sitting in the office for 10 minutes and removing the bandage, skin returned to normal; minimal swelling; arm had FROM.
had no reactions to shots other than sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient received BNT162b2 (BNT162B2), on 09Oct2021 as dose 3 (booster), single (Lot number: 301308A) at the age of 73 years for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for blood pressure measurement; CALCIUM; IRON; D3. Vaccination history included: BNT162b2 (DOSE 1, SINGLE , Lot number: EL3302), administration date: 01Feb2021, when the patient was 72-year-old, for Covid-19 immunization, reaction(s): "had no reactions to shots other than sore arm"; BNT162b2 (DOSE 2, SINGLE , Lot number: EN5318), administration date: 01Mar2021, when the patient was 73-year-old, for Covid-19 immunization, reaction(s): "had no reactions to shots other than sore"; Shingrix (Vaccine/Brand Name: Shingles Shot; Shingrix; , 2 shots before COVID so 2018 Vaccination Date: long time ago), administration date: 2008, for Immunization, reaction(s): "flu", "feverish". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "had no reactions to shots other than sore arm".
Diarrhea; Loss of appetite; Body Aches; Fever; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DECREASED APPETITE (Loss of appetite), MYALGIA (Body Aches), PYREXIA (Fever) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), DECREASED APPETITE (Loss of appetite), MYALGIA (Body Aches), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, DIARRHOEA (Diarrhea), DECREASED APPETITE (Loss of appetite), MYALGIA (Body Aches) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Treatment medication was not provided.    Reporter did not allow further contact
Patient was seen by me via telehealth for follow up after ED visit to Hospital on 5/26/21. On 5/26/21 patient was riding his bike, felt like his legs were heavy and lost consciousness. He said that prior to losing consciousness his vision was blurry and sounds sounded distant. Mother witnessed event and stated he had shaking of his upper extremities for a few seconds woke up and then had repeat shaking and loss of consciousness with eyes rolling up.  He was taken by EMS to  Hospital where evaluation per report was normal (labs, CT head, EKG)
administrated /an expired dose of Engerix-b on April 21 2021/ expired on April 8 2021.; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a female patient who received HBV (Engerix B) (batch number A35ML, expiry date 8th April 2021) for prophylaxis.   On 21st April 2021, the patient received Engerix B. On 21st April 2021, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were reported as follows: The age at vaccination was not reported. The patient was administrated with an expired dose of Engerix B, which led to expired vaccine used. No adverse event was reported. The reporter did not consent to follow up.
Soreness of the arm; Fatigue; Feeling kind of feverish; This is a spontaneous report from a contactable consumer or other non hcp (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 28Mar2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced soreness of the arm, fatigue, feeling kind of feverish on an unspecified date. It was reported that patient had taken the Pfizer shot on Sunday, 28th March and patient was in the first day, He noticed soreness of the arm and now he was feeling kind of feverish. Patient was feeling kind of fatigued, tired. Patient was just wanting to know - are those okay symptoms? The outcome for all events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
30 year old woman who presents for evaluation of hives. She started to break out in hives within 10 hours after her Moderna vaccine. She had no problems with the first 2 doses, though she was pregnant during that time. She states that the hives have mostly been on her trunk, but can be on her arms and legs as well.
my arm was big and inflamed; red maculopapular rash; redness; small lump; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE MASS (small lump), VACCINATION SITE INFLAMMATION (my arm was big and inflamed), RASH MACULO-PAPULAR (red maculopapular rash) and VACCINATION SITE ERYTHEMA (redness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced VACCINATION SITE MASS (small lump) and VACCINATION SITE ERYTHEMA (redness). On 15-Jan-2021, the patient experienced VACCINATION SITE INFLAMMATION (my arm was big and inflamed) and RASH MACULO-PAPULAR (red maculopapular rash). At the time of the report, VACCINATION SITE MASS (small lump), VACCINATION SITE INFLAMMATION (my arm was big and inflamed), RASH MACULO-PAPULAR (red maculopapular rash) and VACCINATION SITE ERYTHEMA (redness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. The patient reported that red maculopapular rash was completely gone on day 14.
Initial unsolicited report received from a nurse on 30 December 2015. This case is a cluster of three cases and linked with 2015SA153209 and 2016SA003166 (same vaccine, different patient). This case involves a 43-year-old female patient who was vaccinated with a dose of FLUZONE QIV (batch number: UI445AC, expiry date: 30 June 2016) in left deltoid on an unknown date. The patient medical history such as allergic to egg or egg products, allergic to flu vaccine, history of guillain barre symdrome, allergic to thiomersal, allergic to latex reported as no. The patient was not pregnant at the time of  vaccination. Concomitant medications were not reported. On an unknown date, following the vaccination, the patient had developed aches, chills, fever and went home from work as thought she had a virus. It was reported that the patient had not worked the day after but fine within 24 hours of vaccination. Laboratory data and corrective treatment was not reported. The patient was recovering from all the events. It was reported that the patient felt better 14 day later. List of documents held by sender: none.
Deveoped severe abdominal pain after injection. Went to ER and got dizzy, nearly fainted. Vomiting, hypotension
Headache, Myalgia & NauseaVomiting Narrative: HA, fatigue, burning (temp 98.8), chills, myalgia, soreness, lightheaded, sob, nausea, nasal congestion, sore throat . x 6 days after receiving vaccine. day 7 had covid test which was negative.
I tested positive for COVID-19 on May 09, 2023, My symptoms are a fever, body aches, congestion, cough, and headaches. I was prescribed PAXLOVID for my symptoms. PAXLOVID made me nauseous so I discontinued it.
This spontaneous report was received from a medical assistant referring to multiple unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA, lot # N016805 with expiration date 04-SEP-2018, lot# N012324 with expiration date 05-APR-2018, lot# N014945 with expiration date 31-AUG-2018, and lo# N008823 with expiration date 26-MAY-2018, for prophylaxis. No adverse event was reported. The doses of VAQTA were exposed to a temperature excursion of 47 degrees Fahrenheit (°F) to 77 °F during a time frame of 2 hours 45 minutes which was detected by the data logger. Previous temperature excursion was reported as 47 °F to 77 °F for 45 minutes. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1708USA002993: US-009507513-1708USA002994: US-009507513-1708USA002995: US-009507513-1708USA002863.
102.5°F fever, joint pain, muscle pain, headache, chills, sweats
Dull pain in injection shoulder two weeks after injection. Major discomfort. Unable to sleep comfortably. Advil doesn?t help. Ice has helped some.
chill; Headache; Fatigue; Mild fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chill), HEADACHE (Headache), FATIGUE (Fatigue) and PYREXIA (Mild fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced CHILLS (chill), HEADACHE (Headache), FATIGUE (Fatigue) and PYREXIA (Mild fever). The patient was treated with FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) at an unspecified dose and frequency. At the time of the report, CHILLS (chill), HEADACHE (Headache), FATIGUE (Fatigue) and PYREXIA (Mild fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included Thyroid Medication.
dizziness; flushing; HA (Headache); This is a spontaneous report from a non-contactable healthcare professional. A 51-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date, then the second dose (lot number: EK9231, expiry date not reported) via intramuscular route of administration the left deltoid muscle on 06Jan202, both at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was given the Pfizer vaccination in the left deltoid muscle. During her 15-minute waiting period after the injection, the patient began to experience dizziness, flushing and HA (headache). She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, and lightheadedness. No therapy/ treatment was given. Events were non-serious. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
24-36 hours after pneumococcal vaccination, developed erythema/tenderness over pneumococcal injection site, fever, chills. Fevers up to 101. Had difficulty using arm. Treated with Levofloxacin 750 PO for 5 days. Symptoms improved within 24 hours.
Patient reported that approximately 10 days after receiving vaccination, she developed a rash along same arm. However, it was not at injection site.
On 10/25/2010 patient presented with abnormal reddening and blistering of (L) arm in site of injection measuring 9 inches in length and 4 inches in width. Painful, prescribed BENADRYL and Ibuprofen.
2 DAYS POST 2ND DOSE, LYMPHADENOPATHY OF LEFT AXILLARY AND HEAVINESS IN LEFT MAMMORY TISSUE. 7 DAYS POST 2ND DOSE, BEGAN EXPERIENCING PAIN IN THE PERI-AURICULAR AREA OF RIGHT EAR.  DAY 8 LYMPHADENOPATHY OF RIGHT CERVICAL AND RIGHT MAXILLARY NODES
couple of days p/vax began itching lt eye & rt hand, next day hives on bridge of nose, both hands, had whelps, both eyes became red & swollen, swollen lips, whelps on ankles-some areas improved others keep cropping up
Immediately developed Pfizer myocarditi - Had numerous tests done, EKG, Echocardiograms, Nuclear Stress Tests - Several rounds of Prednisone, Furosemide, Codene cough medicine, put on Nebulizer treatment, etc. - After 4 months of these treatments, still no resolution, still have myocarditis showing in last echocardiogram - Also had extensive pulmonary assessment completed - no issues identified - Now referred to local Cardiology group for further assessment and resolution  - First appointment is on Friday, January 28, 2022 - Never had any heart related issues until this second Pfizer shot!
Lightheadness rapid heart beat dizziness rash 4 inches by 8 inches oval at injection site arm hard at injection site.
Received booster dose after receiving 3 doses; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (Received booster dose after receiving 3 doses) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028K21A, 037F21A, 010A21A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 21-Dec-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 ml. On 21-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL OVERDOSE (Received booster dose after receiving 3 doses). On 21-Dec-2021, ACCIDENTAL OVERDOSE (Received booster dose after receiving 3 doses) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment was received.
Football-shaped, raised, red rash appeared over left bicep. No itching or tenderness.    Significant history: in 2012 I had shingles on my back.  After the acute phase, a football-shaped, raised swollen area appeared over my left lower abdomen.  The swelling and rash resolved after ~ 6 months.  Confirmed by a dermatologist as a rare occurrence following shingles.
24hrs after injection the site was swollen and painful, difficulty moving arm in normal motions. Arm pain subsided after 24hrs. However, starting from 4/14/21 (day after injection) a 2.5" round bulls-eye style lesion has remain at the injection site. It is warm but not painful to touch, and experiencing recurring moments of moderate itchiness. At time of this report (10:56am PT, 4/25/21) the lesion remains primarily unchanged. Issue is mild, but persisting.
This spontaneous report was received from two registered nurses referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On unspecified dates in October and December 2016, the patient received the first and second dose respectively of GARDASIL 9 and on 28-FEB-2017, the patient received the third dose of GARDASIL 9 (inappropriate schedule of drug administration) (route of administration, lot numbers and expiration dates for all doses were not provided) for prophylaxis. No adverse effect was reported. Additional information has been requested.
Tenderness to site -woke her during night when laying on affected side (left deltoid). Next day area red with blotchy area that spread to inner aspect of left arm by that night (Wed 11/16). Tenderness to touch that extended to left breast and neck. Took Cipro and Benadryl --- by next morning Thursday 11/17 area still red and blotchy with some tenderness but improved from day before.
Initial report received on 02 October 2009 from a consumer. A 56 year old female patient with a "low thyroid" and allergies to mold, ragweed, KEFLEX, and BACTRIM complained of congestion "with lots of phlegm", ear congestion, watery, blurry eyes twelve hours after receiving FLUZONE SV (lot number not known) intramuscularly in the right deltoid on 25 September 2009. The patient stated that the vaccine appeared to be pink in color. On 27 September 2009 the patient went to the emergency room and was treated with PREDNISONE and ZITHROMAX. On 30 September 2009 the patient was seen again in the emergency room. No further treatment was given at that time. Concomitant therapy included herbals, "bp meds", Synthroid, oils, and vitamins. Diagnostics included: EKG (results not provided), CT chest which revealed bronchitis (dates not specified). On 27 September the patient had a negative flu test. The patient's recovery status was unknown. List of Documents held by Sender: none.
I also took the flu shot at the same time of taking the booster. A couple of months after taking the 3rd dose, I get nosebleeds now that I did not have before and my sinuses are off. I am also having abdominal problems, short stabbing pain, and I am losing my appetite. I am very low on vitamins like iron and B12.
sudden onset neck stiffness, abd pain, aching, low grade fever 103, chills;still felt ill late afternoon;seen by MD early PM 9OCT feels better this AM;
Information has been received from a registered nurse regarding a patient of an unknown age and gender. On 03-SEP-2013 at 07:30, ZOSTAVAX lot # J003360 was exposed to an exact T not recorded but noted as equal to or > 12C for an estimated total time out of range of 72.0 hours. On 10-SEP-2013 at 17:30, ZOSTAVAX lot # J003360 was exposed to -13C for an estimated total time out of range of 10 hours. On 16-SEP-2013 at 17:30, ZOSTAVAX lot # J003360 was exposed to -14C for an estimated total time out of range of 10 hours. On 25-SEP-2013 at 07:30, ZOSTAVAX lot # J003360 was exposed to 11C for an estimated total time out of range of 14 hours. On 07-OCT-2013 at 07:30, ZOSTAVAX lot # J003360 was exposed to an exact T not recorded but noted as equal to or <12C for an estimated total time out of range of 42.5 hours. On 15-OCT-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route administration were not provided) (Lot number J003360, Exp. Date: 21-JUN-2014). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.